Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases

AIDS

Volumn 16, Issue 15, 2002, Pages 2043-2047

  Price, Patricia ^a   Morahan, Grant ^a   Huang, Dexing ^a   Stone, Emma ^a   Cheong, Karey Y M ^a   Castley, Alison ^a   Rodgers, Marina ^a   McIntyre, Meredith Q ^a   Abraham, Lawrence J ^a   French, Martyn A ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Anti retroviral therapy; Cytokine genes; Cytomegalovirus; HIV; Polymorphism

Indexed keywords

CYTOKINE; HLA A2 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HLA TYPING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MYCOBACTERIOSIS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CYTOKINES; CYTOMEGALOVIRUS RETINITIS; ENCEPHALOMYELITIS; GENETIC PREDISPOSITION TO DISEASE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE SYSTEM; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; POLYMORPHISM, GENETIC;

EID: 0037131211     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200210180-00009     Document Type: Article

References (23)

1. French MA, Lenzo N, John M, Mallal SA, McKinnon EJ, James, et al. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med 2000, 1:107-115.
2. DeSimone JA, Pomerantz RJ, Babinchak TJ. Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med 2000, 133:447-454.
3. French MA, Price P. Immune restoration disease in HIV patients: aberrant immune responses after antiretroviral therapy. J HIV Therapy 2002, 7:46-51.
4. French MA, Mallal SA, Dawkins RL. Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients. AIDS 1992, 6:1293-1297.
5. Stone SF, Price P, Tay-Kearney M-L, French MA. Cytomegalovirus (CMV) retinitis immune restoration disease occurs during HAART-induced restoration of CMV-specific immune responses within a predominant T2 cytokine environment. J Inf Dis 2002, 185:1813-1817.
6. Stone SF, Lee S, Keane NM, Price P, French MA. Hepatotoxicity after HAART in HIV/HCV co-infected patients is associated with increased HCV-specific IgG and sCD26 (DPP IV) enzyme activity. J Infect Dis 2002, (in press).
7. Foudraine NA, Hovenkamp E, Notermans DW, Meenhorst PK, Klein MR, Lange JMA, et al. Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients. AIDS 1999, 13:177-184.
8. Karavellas MP, Azen SP, Macdonald JC, Shufelt CL, Lowder CY, Plummer DJ, et al. Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes. Retina 2001, 21:1-9.
9. Price LM, O'Mahoney C. Focal adenitis developing after immune reconstitution with HAART. Int J STD AIDS 2000, 11:685-686.
10. Murcia JM, Boix V, Merino E, MI Manso, J Portilla, et al. Drug toxicity or syndrome of immune restoration causing fulminant cirrhosis after HAART-induced immune recovery. Eur J Clin Microbiol Infect Dis 2002, 21:153-155.
11. Miralles P, Berenguer J, Lacruz C, Cosín J,López JC, Padilla B, et al. Inflammatory reactions in progressive multifocal leukoence-phalopathy after highly active antiretroviral therapy. AIDS 2001, 15:1900-1902.
12. Price P, Keane NM, Stone SF, Cheong KY, French MA. MHC haplotypes affect the expression of opportunistic infections in HIV patients. Human Immunol 2001, 62:157-164.
13. Hassell M, French MA. Mycobacterium avium infection and immune restoration disease after highly active antiretroviral therapy in a patient with HIV and normal CD4+ counts. Eur J Clin Microbiol Infect Dis 2001, 20:889-891.
14. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels and an association with systemic onset juvenile chronic arthritis. J Clin Invest 1998, 102:1369-1376.
15. Wilson AG, Clay FE, Crane AM, Cork MJ, Duff GW. Comparative genetic association of human leukocyte antigen class II and tumor necrosis factor-alpha with dermatitis herpetiformis. J Invest Dermatol 1995, 104:856-858.
16. Morahan G, Huang D, Ymer SI, Cancilla MR, Stephen K, Dabadghao, et al. Linkage disequilibrium of a type 1 diabetes susceptibility locus with a IL12B allele. Nature Genet 2001, 27:218-221.
17. Morahan G, Huang D, Wu M, Holt BJ, White GP, Kendall GE, et al. The severity of both atopic and nonatopic asthma in children is associated with IL12B polymorphism. Lancet 2002, 360:455-459.
18. Price P, Calder DM, Witt CM, Allcock RN, Christiansen FT, Davies GR, et al. Periodontal attachment loss in HIV-infected patients is associated with the major histocompatibility complex 8.1 haplotype (HLA-A1,B8, DR3). Tissue Antigens 1999, 54:391-399.
19. Croager EJ, Gout AM, Abraham LJ. Involvement of Sp1 and microsatellite repressor sequences in the transcriptional control of the human CD30 gene. Am J Pathol 2000, 156:1723-1731.
20. Phillips P, Chan K, Hogg R, Bessuille E, Black W, Talbot J et al. Azithromycin prophylaxis for Mycobacterium avium complex during the era of highly active antiretroviral therapy: evaluation of a provincial program. Clin Infect Dis 2002, 34:371-378.
21. Price P, Witt C, Allcock R, Sayer D, Garlepp M, Choy Kok C, et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 1999, 167:257-274.
22. Stone SF, Price P, Brochier J, French MA. Plasma bioavailable interleukin-6 is elevated in human immunodeficiency virus-infected patients who experience herpesvirus-associated immune restoration disease after start of highly active antiretroviral therapy. J Inf Dis 2001, 184:1073-1077.
23. Kroager KM, Steer JH, Joyce DA. Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism. Cytokine 2000, 12:110-119.